SINGAPORE & FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI) today announced that its Singapore facility has received an important ISO quality certification, enhancing the company’s ability to serve its customers in applied and validated markets. The British Standards Institution Americas, Inc. has awarded the company with an ISO 13485:2003 certification for in-vitro diagnostic medical devices. This is a stringent, globally recognized management system standard that enables CE Marking to the In-Vitro Diagnostics Directive 98/79/EC of products for sale within the European Community. The CE Mark certifies that a product has met European Union health, safety, and environmental requirements, which are intended to ensure consumer safety.
